Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin

BACKGROUND: To explore whether combining inhibitors that target the insulin-like growth factor receptor (IGFR)/PI3K/Akt/mTOR signaling pathway (vertical blockade) can improve treatment efficacy for hepatocellular carcinoma (HCC). METHODS: HCC cell lines (including Hep3B, Huh7, and PLC5) and HUVECs (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Da-Liang, Lee, Bin-Shyun, Lin, Liang-In, Liou, Jun-Yang, Liao, Sheng-Chieh, Hsu, Chiun, Cheng, Ann-Lii
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882101/
https://www.ncbi.nlm.nih.gov/pubmed/24387108
http://dx.doi.org/10.1186/1476-4598-13-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882101/
https://www.ncbi.nlm.nih.gov/pubmed/24387108
http://dx.doi.org/10.1186/1476-4598-13-2

Ejemplares similares